Literature DB >> 32039603

Fluorinated α-Helical Polypeptides Synchronize Mucus Permeation and Cell Penetration toward Highly Efficient Pulmonary siRNA Delivery against Acute Lung Injury.

Chenglong Ge1, Jiandong Yang1, Shanzhou Duan2, Yong Liu1, Fenghua Meng3, Lichen Yin1.   

Abstract

The mucus layer and cell membrane are two major barriers against pulmonary siRNA delivery. Commonly used polycationic gene vectors can hardly penetrate the mucus layer due to the adsorption of mucin glycoproteins that trap and destabilize the polyplexes. Herein, guanidinated and fluorinated bifunctional helical polypeptides were developed to synchronizingly overcome these two barriers. The guanidine domain and α-helix facilitated trans-membrane siRNA delivery into macrophages, whereas fluorination of the polypeptides dramatically enhanced the mucus permeation capability by ∼240 folds, because incorporated fluorocarbon segments prevented adsorption of mucin glycoproteins onto polyplexes surfaces. Thus, when delivering TNF-α siRNA intratracheally, the top-performing polypeptide P7F7 provoked highly efficient gene knockdown by ∼96% at 200 μg/kg siRNA and exerted pronounced anti-inflammatory effect against acute lung injury. This study thus provides an effective strategy for transmucosal gene delivery, and it also renders promising utilities for the noninvasive, localized treatment of inflammatory pulmonary diseases.

Entities:  

Keywords:  Anti-inflammation therapy; cell penetration; fluorination; helical polypeptide; mucus permeation; pulmonary siRNA delivery

Mesh:

Substances:

Year:  2020        PMID: 32039603     DOI: 10.1021/acs.nanolett.9b04957

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  13 in total

Review 1.  Non-viral vectors for RNA delivery.

Authors:  Yi Yan; Xiao-Yu Liu; An Lu; Xiang-Yu Wang; Lin-Xia Jiang; Jian-Cheng Wang
Journal:  J Control Release       Date:  2022-01-10       Impact factor: 9.776

2.  Hyaluronate-coated perfluoroalkyl polyamine prodrugs as bioactive siRNA delivery systems for the treatment of peritoneal cancers.

Authors:  Ao Yu; Siyuan Tang; Ling Ding; Jackson Foley; Weimin Tang; Huizhen Jia; Sudipta Panja; Cassandra E Holbert; Yu Hang; Tracy Murray Stewart; Lynette M Smith; Diptesh Sil; Robert A Casero; David Oupický
Journal:  Biomater Adv       Date:  2022-03-17

Review 3.  Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.

Authors:  Makhloufi Zoulikha; Qingqing Xiao; George Frimpong Boafo; Marwa A Sallam; Zhongjian Chen; Wei He
Journal:  Acta Pharm Sin B       Date:  2021-08-12       Impact factor: 11.413

Review 4.  Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.

Authors:  Qi Qiao; Xiong Liu; Ting Yang; Kexin Cui; Li Kong; Conglian Yang; Zhiping Zhang
Journal:  Acta Pharm Sin B       Date:  2021-05-07       Impact factor: 11.413

Review 5.  Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung.

Authors:  Daiqin Chen; Jinhao Liu; Jerry Wu; Jung Soo Suk
Journal:  Expert Opin Drug Deliv       Date:  2020-12-07       Impact factor: 8.129

Review 6.  Nanomedicine-Based Therapeutics to Combat Acute Lung Injury.

Authors:  Youbin Cui; Wanguo Liu; Shuai Bian; Hongfei Cai; Chunsheng Xiao
Journal:  Int J Nanomedicine       Date:  2021-03-18

7.  Perfluorocarbon Nanoemulsions Enhance Therapeutic siRNA Delivery in the Treatment of Pulmonary Fibrosis.

Authors:  Ling Ding; Siyuan Tang; Weimin Tang; Deanna D Mosley; Ao Yu; Diptesh Sil; Svetlana Romanova; Kristina L Bailey; Daren L Knoell; Todd A Wyatt; David Oupický
Journal:  Adv Sci (Weinh)       Date:  2022-01-07       Impact factor: 16.806

Review 8.  Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer.

Authors:  Chengyuan Zhang; Xuemei Zhou; Hanyi Zhang; Xuanliang Han; Baijun Li; Ran Yang; Xing Zhou
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

9.  Macrophage-targeting gene silencing orchestrates myocardial microenvironment remodeling toward the anti-inflammatory treatment of ischemia-reperfusion (IR) injury.

Authors:  Yao Wang; Mengying Hou; Shanzhou Duan; Ziyin Zhao; Xuejie Wu; Yongbing Chen; Lichen Yin
Journal:  Bioact Mater       Date:  2022-02-01

10.  Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies.

Authors:  Xin Wang; Bin Yang; Lingxiao Li; Tian Liu; Shiyi Zuo; Dongxu Chi; Zhonggui He; Bingjun Sun; Jin Sun
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.